Recruiting · registry status

Learning from heat-based procedures for brain and nerve conditions

Researchers collect everyday treatment results from procedures that use radiofrequency energy to treat targeted tissue in the brain and nervous system.

Learning by observing or collecting information · Study reference: NCT06553625

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

Open the official registry record ↗

Who can join?

Age range not listed · Does not accept healthy volunteers

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU) * Signed a valid, IRB/EC/REB-approved informed consent form Exclusion Criteria: * Meets any contraindications per locally applicable Directions for Use (DFU) * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Full study name & original research details

Official study title

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System

Short title used by the registry

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Original description

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Further description from the registry

The objective of this study is to compile real-world outcomes of Boston Scientific Corporation commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Conditions reported: Parkinson Disease; Dystonia; Essential Tremor; Movement Disorders

Study type: Observational
Interventions: Radiofrequency Ablation
Phases: Not reported
Sponsor: Boston Scientific Corporation
Start date reported by registry: 2024-01-29 (actual)

Registry updated: 2026-09-11 · Status last verified by the registry submitter: 2026-09

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Stephanie Delvaux · 855-213-9890 · BSNClinicalTrials@bsci.com

Diane Keesey · 855-213-9890 · BSNClinicalTrials@bsci.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Uniklinik Köln

Cologne, Germany

Recruiting

Boston Scientific Clinical Research · 855-213-9890 · BSNClinicalTrials@bsci.com

Universitaetsklinikum Dusseldorf

Düsseldorf, Germany

Recruiting

Boston Scientific Clinical Research · 855-213-9890 · BSNClinicalTrials@bsci.com

Universitaetsklinikum Wuerzburg

Würzburg, Germany

Recruiting

Boston Scientific Clinical Research · 855-213-9890 · BSNClinicalTrials@bsci.com

St. Georges Hospital

London, United Kingdom

Recruiting

Boston Scientific Clinical Research · 855-213-9890 · BSNClinicalTrials@bsci.com

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.